Evidence map›Paper›PMID 41019483›Full record

ArticleExperimental and therapeutic medicine2025

Comparative analysis of treatment modalities and contributing factors in recurrent pilonidal sinus disease.

Jenna Lagus, Heidi-Mari Myllykangas, Henrik Nuutinen

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jenna LagusDepartment of Surgery, University of Eastern Finland, 70210 Kuopio, Finland.
Heidi-Mari MyllykangasDepartment of Plastic Surgery, Kuopio University Hospital, 70211 Kuopio, Finland.
Henrik NuutinenDepartment of Surgery, University of Eastern Finland, 70210 Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pilonidal sinus disease (PSD) is a common and frequently recurring condition affecting young men. Despite the frequent recurrence of PSD, there is a lack of published literature addressing the management of recurrent disease. In the present retrospective study, data from 63 patients with recurrent pilonidal sinuses treated at the Plastic Surgery Department of Kuopio University Hospital (Kuopio, Finland) between 2010 and 2021 were analyzed. Patients were categorized into three groups based on the primary operation: Laser treatment (n=13), excision combined with direct closure (n=32) and flap reconstruction (n=18). The patient characteristics, complications, re-operative methods and follow-up times of these groups were compared. The minimum follow-up time was 18.3 months. Furthermore, ~1 in 5 patients required re-operation after the primary operation: 18.8% after laser treatment, 20.5% after direct closure and 19.2% after flap reconstruction. Residual disease or recurrence was more common as a reason for re-operation in the laser group compared with the other groups (direct closure group, P=0.003; flap group, P=0.010). Direct closure was the most common method for re-operation after primary direct closure and flap reconstruction (56.3 and 55.6%, respectively). However, patients treated primarily with laser were most likely re-operated with laser (61.5%), with only 15.4% operated using secondary direct closure and 23.1% with secondary flap reconstruction. In conclusion, the risk of recurrent PSD remains significant, yet most patients typically required only one re-operation. Laser treatment was a promising approach for both primary and recurrent cases. However, long-term outcomes are necessary to confirm this.

Indexed as

flaplaserpilonidal sinusrecurrentredo

Identifiers

PMID41019483
PMCPMC12464478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.